Free Trial

Sutro Biopharma (STRO) SEC Filings & 10K Form

Sutro Biopharma logo
$1.10 +0.03 (+2.80%)
Closing price 04:00 PM Eastern
Extended Trading
$1.11 +0.01 (+0.91%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sutro Biopharma SEC Filings

DateFilerForm TypeView
04/25/2025
3:30 PM
Sutro Biopharma (Filer)
Form DEF 14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form DEFA14A
04/25/2025
3:33 PM
Sutro Biopharma (Filer)
Form ARS
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G/A
04/08/2025
3:03 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/08/2025
3:05 PM
Pauling David (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:07 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:09 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:11 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
3:12 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:32 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SCHEDULE 13G
03/13/2025
4:14 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
4:17 PM
Sutro Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2025
3:14 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:06 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:09 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
3:12 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:32 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:34 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:40 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:42 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:44 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:57 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
4:58 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:30 PM
Sutro Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/10/2024
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/04/2024
1:09 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/13/2024
3:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:16 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:38 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
3:40 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:10 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:11 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:29 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:31 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)

Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
06/10/2024
3:21 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM
Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:24 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STRO) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners